title: Sphingolipids and mitochondrial apoptosis.
abstract: The sphingolipid family of lipids modulate several cellular processes, including proliferation, cell cycle regulation, inflammatory signaling pathways, and cell death. Several members of the sphingolipid pathway have opposing functions and thus imbalances in sphingolipid metabolism result in deregulated cellular processes, which cause or contribute to diseases and disorders in humans. A key cellular process regulated by sphingolipids is apoptosis, or programmed cell death. Sphingolipids play an important role in both extrinsic and intrinsic apoptotic pathways depending on the stimuli, cell type and cellular response to the stress. During mitochondrial-mediated apoptosis, multiple pathways converge on mitochondria and induce mitochondrial outer membrane permeabilization (MOMP). MOMP results in the release of intermembrane space proteins such as cytochrome c and Apaf1 into the cytosol where they activate the caspases and DNases that execute cell death. The precise molecular components of the pore(s) responsible for MOMP are unknown, but sphingolipids are thought to play a role. Here, we review evidence for a role of sphingolipids in the induction of mitochondrial-mediated apoptosis with a focus on potential underlying molecular mechanisms by which altered sphingolipid metabolism indirectly or directly induce MOMP. Data available on these mechanisms is reviewed, and the focus and limitations of previous and current studies are discussed to present important unanswered questions and potential future directions.
authors.affiliation: Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, 40202, USA.
authors.forename: Gauri A
authors.initials: GA
authors.lastname: Patwardhan
authors.affiliation: Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, 40202, USA.|Department of Medicine, University of Louisville, Louisville, KY, 40202, USA.|James Graham Brown Cancer Center, University of Louisville, 505 South Hancock Street, Clinical and Translational Research Building, Room 203, Louisville, KY, 40202, USA.
authors.forename: Levi J
authors.initials: LJ
authors.lastname: Beverly
authors.affiliation: Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, 40202, USA. leah.siskind@louisville.edu.|James Graham Brown Cancer Center, University of Louisville, 505 South Hancock Street, Clinical and Translational Research Building, Room 203, Louisville, KY, 40202, USA. leah.siskind@louisville.edu.
authors.forename: Leah J
authors.initials: LJ
authors.lastname: Siskind
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D053477:Apoptotic Protease-Activating Factor 1 / Q000235:genetics / Q000378:metabolism; D006801:Humans; D008928:Mitochondria / Q000235:genetics / Q000378:metabolism*; D051336:Mitochondrial Membranes / Q000378:metabolism*; D010539:Permeability; D013107:Sphingolipids / Q000235:genetics / Q000378:metabolism*
chemical_list: C506592:APAF1 protein, human; D053477:Apoptotic Protease-Activating Factor 1; D013107:Sphingolipids
keywords: Apoptosis; Bcl-2 proteins; Cancer; Ceramide; Mitochondria; Sphingolipid